EarlySign, Roche Collaborate on Colon Cancer Detection
EarlySign ColonFlag will now be offered within the navify Algorithm Suite from Roche Diagnostics to improve early detection of colon cancer.
Read MorePosted by Melanie Hamilton-Basich | May 2, 2023 | Colorectal |
EarlySign ColonFlag will now be offered within the navify Algorithm Suite from Roche Diagnostics to improve early detection of colon cancer.
Read MorePosted by Melanie Hamilton-Basich | Apr 28, 2023 | Uncategorized |
Generalist medical AI models can integrate multiple data types — such as MRI scans, X-rays, blood test results, medical texts, and genomic testing — to perform a range of tasks
Read MorePosted by Melanie Hamilton-Basich | Apr 27, 2023 | Company News |
After Quest acquires Haystack, Quest expects to adapt the MRD test developed at Haystack as the basis for new clinical lab services.
Read MorePosted by Andy Lundin | Apr 19, 2023 | Cancer |
Adela demonstrated the ability of its genome-wide methylome enrichment platform to detect a broad set of diverse cancers in early stages.
Read MorePosted by Chris Wolski | Apr 18, 2023 | Lung Cancer |
New data demonstrates Exai Bio’s novel RNA- and AI-based platform detected non-small cell lung cancer with high accuracy.
Read More